Furthermore, we found that members of the FNDC family could be potential therapeutic targets or prognostic markers in several cancers, in line with earlier reports.[39,40] What’s more, we had a few other new findings that upregulated FNDC3A mRNA expression signified better OS in gastric and liver cancer patients. Here, FNDC3A is linked to liver cancer.